'Anti egfr' diaporamas de présentation

Biotecnologie ed Evoluzione della Terapia Medica dei Tumori Solidi

Dr. Francesco Graziano. Medical Oncology Hospital of Pesaro. Biotecnologie ed Evoluzione della Terapia Medica dei Tumori Solidi. European Commette for Genetic Cancer Research. Terapia dei tumori. Stadio I-II. Stadio III. Stadio IV. chirurgia. chemioterapia della malattia metastatica.

1.12k views • 70 slides

Novel treatment strategies in metastatic colorectal cancer patients with KRAS wildtype tumors

Novel treatment strategies in metastatic colorectal cancer patients with KRAS wildtype tumors. Prof.dr. Cornelis Punt Dept. of Medical Oncology Radboud University Nijmegen Medical Center Nijmegen, The Netherlands. Current standard in 1 st line metastatic colorectal cancer.

1.5k views • 39 slides

The Continuation of Biologic Agents Beyond Progression: Does It Make Sense?

The Continuation of Biologic Agents Beyond Progression: Does It Make Sense?. Axel Grothey Mayo Clinic College of Medicine Rochester, MN. Continuation of Chemotherapy Beyond Progression. FOLFOX ? FOLFIRI Tournigand FOLFIRI ? FOLFOX Tournigand LV5FU2 ? FOLFIRI FOCUS LV5FU2 ? FOLFOX FOCUS

484 views • 34 slides

Paul S. Mischel, M.D. The Lya and Harrison Latta Professor of Pathology

Towards a future of personalized cancer care for glioblastoma patients through development and implementation of novel molecular diagnostic tools. Paul S. Mischel, M.D. The Lya and Harrison Latta Professor of Pathology The David Geffen UCLA School of Medicine

443 views • 22 slides

Johanna Bendell, MD Director, GI Oncology Research Associate Director, Drug Development Program

346 views • 21 slides

Developing Novel Supported Membrane Interfaces for SPR Study of Transmembrane Proteins

101 views • 1 slides